Equity

Adverse drug events or reactions are major causes of patient morbidity and mortality, and a source of significant costs for organisations and whānau

How often are pharmacies stepping up to devise innovative payment plans for patients who struggle to afford the copayment, and at what cost? Anna Lee investigates

How often are pharmacies stepping up to devise innovative payment plans for patients who struggle to afford the copayment, and at what cost? Anna Lee investigates

Māori attitudes to healthcare today are deeply rooted in New Zealand history. In this article, Deborah Bassett-Clarke discusses some reasons why the current model of pharmacy practice does not always meet the needs of Māori and may actually cause health inequities. Understanding these factors is an important first step to improving outcomes for Māori

The Hutt Valley DHB is standing by its decision to enter into a funding agreement for a new Countdown Pharmacy in Wainuiomata, despite the panel that assesses new pharmacy contracts voting against the proposal four to one

It is “crucial” to indigenise your pharmacy in order to establish a culturally safe environment as the existing one-sided systems fail, according to health researcher and psychiatrist Diana Kopua. Anna Lee reports  

It is “crucial” to indigenise your pharmacy in order to establish a culturally safe environment as the existing one-sided systems fail, according to health researcher and psychiatrist Diana Kopua. Anna Lee reports  

The Government’s new scheme of providing free period products in schools nationwide will be a “circuit breaker”, says Wellington academic Terry Fleming 

The Ministry of Health has ­revealed only 4150 of 350,000 MMR vaccines bought last year for a targeted programme have been administered since July 2020, and only 45 by pharmacist vaccinators 

The Ministry of Health has ­revealed only 4150 of 350,000 MMR vaccines bought last year for a targeted programme have been administered since July 2020, and only 45 by pharmacist vaccinators